Barclays PLC Matinas Bio Pharma Holdings, Inc. Transaction History

Barclays PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$0.75 - $1.1 $11,151 - $16,354	-14,868 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$0.96 - $1.74 $14,273 - $25,870	14,868 New	14,868 $16,000
Q4 2020 Feb 11, 2021	SELL	$0.76 - $1.47 $9,570 - $18,511	-12,593 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$0.67 - $0.96 $8,437 - $12,089	12,593 New	12,593 $10,000
Q4 2019 Feb 10, 2020	SELL	$0.63 - $2.27 $12 - $45	-20 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.79 - $1.11 $53,426 - $75,067	-67,628 Reduced 99.97%	20 $0
Q1 2019 May 15, 2019	BUY	$0.6 - $1.41 $40,588 - $95,383	67,648 New	67,648 $74,000
Q3 2018 Nov 14, 2018	SELL	$0.35 - $0.92 $350 - $920	-1,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$0.42 - $0.74 $5,300 - $9,338	-12,620 Reduced 92.66%	1,000 $0
Q1 2018 May 15, 2018	BUY	$0.76 - $1.32 $2,470 - $4,291	3,251 Added 31.35%	13,620 $11,000
Q4 2017 Feb 14, 2018	BUY	$1.1 - $1.54 $10,059 - $14,083	9,145 Added 747.14%	10,369 $12,000
Q3 2017 Nov 14, 2017	BUY	$1.19 - $1.43 $1,456 - $1,750	1,224	1,224 $2,000

2.74M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $132M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.